Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

November 18, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Jellyfish creates a ‘virtual wall’ to enhance performance

AXL receptor: a new companion of the ACE2 receptor which helps SARS-CoV-2 to enter the human body

'Good bacteria' can now fight against Enteric Diseases!!!

Jellyfish creates a ‘virtual wall’ to enhance performance
  • BiotechToday
  • World

Jellyfish creates a ‘virtual wall’ to enhance performance

bioxone January 17, 2021January 17, 2021

Arjama Roy, Amity University Kolkata

Jellyfishes are known as the world’s most efficient swimmer. New research has uncovered one of the reasons why jellyfish have come to be known as the world’s most efficient swimmer. They have discovered a way to achieve a ‘ground effect’ type boost in open water, far from any solid surfaces. Experiments have shown that jellyfish uses their two vortex rings in place of the ground. The vortex rings resist one another, which creates a “virtual wall” that has the same boost in performance compared to animals that swim near the bottom.  

An experiment carried out by Brad Gemmell, where the movements of eight jellyfish (Aurelia aurita) were captured in a glass filming vessel using a high-speed camera at 1,000 frames per second. It had been observed that jellyfish that were in motion had a 41% increase in maximum swimming speed and a 61% increase in cumulative distance travelled per swimming cycle compared to those starting from rest. Jellyfish don’t produce cavitation bubbles and are silent which allows them to move quietly through the water. The high efficiency of swimming helps them store energy for growth and reproduction.

Also read:AXL receptor: a new companion of the ACE2 receptor which helps SARS-CoV-2 to enter the human body

Source: Brad J. Gemmell, Kevin T. Du Clos, Sean P. Colin, Kelly R. Sutherland, John H. Costello. The most efficient metazoan swimmer creates a ‘virtual wall’ to enhance performance. Proceedings of the Royal Society B: Biological Sciences, 2021; 288 (1942): 20202494 DOI: 10.1098/rspb.2020.2494

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged Aurelia aurita Biology ground effect jellyfish marine life stinging cells swimmers tentacles virtual wall vortex rings

One thought on “Jellyfish creates a ‘virtual wall’ to enhance performance”

  1. Pingback: 'Good bacteria' can now fight against Enteric Diseases!!! - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

'Good bacteria' can now fight against Enteric Diseases!!!

bioxone January 17, 2021

Camelia Bhattacharyya, Amity University Kolkata Gut microbiota, a term very commonly heard and seen in advertisements regarding health drinks and prescriptions rated to stomach infections. The design of one person’s gut always differs from that of others and most fascinatingly, the design changes and is not constant. The gut microbiome depends on food, sleep, exercise, […]

Good bacteria

Related Post

  • BiotechToday
  • World

Depressive disorders and Pharmacotherapy: New info revealed!

BioTech Today July 25, 2021July 24, 2021

Soumya Shraddhya Paul, Amity University, Noida In 2017, depressive disorders were the third biggest cause of non-fatal illness burden worldwide. In the treatment of depressive disorders, pharmacotherapy is an essential component. As of now, the treatment consists of monotherapy using second-generation antidepressants, such as selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

WILL COVID-19 VACCINE WORK?

bioxone October 31, 2020October 30, 2020

Chitra Roy, University of Calcutta As we are getting closer to the COVID-19 vaccine, it is exciting to think of the day when the virus will be gone. But, the COVID-19 vaccine will not be the magic bullet considering its efficacy and the challenges currently being faced in these efficacy studies. Efficacy of a vaccine […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

A potential Covid vaccine for Multiple Myeloma Patients

BioTech Today July 4, 2021July 4, 2021

Saptaparna Dasgupta, Bennett University The risk of COVID19 infection is exceeded in multiple myeloma patients. Vaccine for the general population with BNT162b2 mRNA COVID19 (BNT162b2) provides effective protection against COVID19. However, their efficacy on patients with multiple myeloma may be adversely affected by and not yet assessed due to factors related to disease and therapy. […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy